Author(s):
B. Ramu, Kaushal K. Chandrul, P. Shanmuga Pandiyan
Email(s):
Email ID Not Available
DOI:
10.5958/0974-360X.2021.00126.8 
Address:
B. Ramu1*, Dr. Kaushal K. Chandrul2, Dr. P. Shanmuga Pandiyan3
1Research Scholar, Mewar University, Gangrar, Chittorgarh, Rajasthan-312901, India.
2Research Supervisor, Dean and Professor, Department of Pharmaceutical Sciences, Mewar University,
Gangrar, Chittorgarh, Rajasthan-312901, India.
3Research Co-Supervisor, Department of Pharmacy, Mewar University, Gangrar, Chittorgarh, Rajasthan-312901, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 2,
Year - 2021
ABSTRACT:
Objective: Floating tablets of repaglinide were developed using hydrophilic polymers like HPMC (hydroxy propyl methyl cellulose) K4M, HEC (hydroxy ethyl cellulose) and Chitosan to control the water uptake and effervescent agent, NaHCO3(sodium bicarbonate) used for buoyancy of the system, to prepare a stable formulation and to prolong gastric residence time leading to an increase in drug bioavailability. Method: Tablets are prepared by direct compression technique using polymers Chitosan, HPMC K4M, HEC, and sodium bicarbonate. In-vitro floating properties, and In-vitro drug release. Gastro retentive drug delivery systems were optimized by 24 factorial designs of four variables at two levels. Results: Tablets were evaluated for their physical characteristics viz., hardness, thickness, friability and weight variation, drug content and floating properties. The best formulation subjected for kinetic treatment. i.e., zero order, first order, peppas, Higuchi, and Hixon Crowell. Conclusion: Repaglinide floating tablets was successfully optimized by using 24 factorial design and HPMC K4M, HEC, Chitosan were used as retarding materials for controlling the drug release. Sodium bi carbonate was helped to maintenance the gastro retentive system density. The optimized formulation (F16) was followed the fickian diffusion of drug release the reproducible drug release kinetic values were indicating that, this method of preparation is acceptable.
Cite this article:
B. Ramu, Kaushal K. Chandrul, P. Shanmuga Pandiyan. Using 24 Factorial Designs optimization of Repaglinide Gastroretentive Drug Delivery System. Research J. Pharm. and Tech. 2021; 14(2):725-729. doi: 10.5958/0974-360X.2021.00126.8
Cite(Electronic):
B. Ramu, Kaushal K. Chandrul, P. Shanmuga Pandiyan. Using 24 Factorial Designs optimization of Repaglinide Gastroretentive Drug Delivery System. Research J. Pharm. and Tech. 2021; 14(2):725-729. doi: 10.5958/0974-360X.2021.00126.8 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-2-22
REFERENCES:
1. Amidon GL. A theoretical basis for a bio pharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res.1995; 13: 413-420.
2. Dressman JB, Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 2000; 11: S73-S80.
3. Landgraf R, Frank M, Bauer C, Dieken M. Prandial glucose regulation with repaglinide: it’s clinical and lifestyle impact in a large cohort of patients with Type II diabetes. Int J Obesity. 2000; 24: S38-S44.
4. Wang F. Focus on repaglinide: an oral hypoglycaemic agent with a more rapid onset and shorter duration of action than the sulfonylureas, Formulary. 1998; 33:1028-1081.
5. S Gopalakrishnan, A Chenthilnathan. Formulation and In Vitro evaluation of Aceclofenac oral floating tablets. Research J. Pharm. and Tech. 4(4): April 2011; Page 642-645.
6. Bandameedi R, Pandiyan PS. Formulation and evaluation of gastro retentive floating bioadhesive tablets of hydrochlorothiazide. Asian J Pharm Clin Res 2017;10: 150-5.
7. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Varghese publishing house, bombay. 3rdedn. 1991, page no: 184.
8. Sahu Chandra Mohan, Chandira R. Margret, Vaidya Shivani, Tiwari D.K., Sharma Sarvesh, S.J. Ingale, Singhai A.K. Design and In-vitro Buoyancy Evaluation of Floating Tablets of Diltiazem Hydrochloride. Research J. Pharm. and Tech. 5(3): Mar.2012; Page 337-341
9. Srujana Kumari D., Balasubramaniam V., Velrajan G., Deepthi N., Sushma R. Formulation and Evaluation of Bilayer Floating Tablets of Metformin Hydrochloride and Glibenclamide. Research J. Pharm. and Tech. 6(1): Jan. 2013; Page 105-111.
10. Varma MM, Suneetha S, Raju DB. Design and Evaluation of Floating Drug Delivery System of Furosemide. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 452-454.
11. Seema M. Dhole, Pramod B. Khedekar, Nikhil D. Amnerkar. Validated HPTLC Method for Determination of Repaglinide in Bulk and Tablet Dosage Form. Asian J. Research Chem. 6(3): March 2013; Page 268-271
12. Kiran Deshpande, Pranjali Ranaware, A. R. Madgulkar, M.C. Damle. Development and Validation of Stability Indicating HPTLC Method for Determination of Repaglinide. Research J. Pharm. and Tech. 6(2): Feb. 2013; Page 158-161.
13. R. Divya, S. Sivaneswari, N. Preethi, B. Mounika, G. Hemalatha B. Naveen Kumar, J. Jayasree, S. Vasudeva Murthy. Research J. Pharm. and Tech. 7(7): July 2014 Page 798-804.
14. Hyma Ponnaganti, Abbulu. K. Enhanced Dissolution of Repaglinide: SMEDDS Formulation and In-vitro Evaluation. Research J. Pharm. and Tech. 7(11): Nov. 2014 Page 1246-1252.